Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity Post author: Post published:December 1, 2023 Post category:uncategorized The impact of semaglutide and tirzepatide and glucagon-like peptide-1 receptor agonist medications on alcohol consumption. You Might Also Like Kids’ exposure to unhealthy food ads on TV drops, but remains high August 26, 2024 High-intensity exercise increases adiponectin concentrations in human breast milk March 14, 2024 DuPont to acquire Donatelle Plastics Incorporated June 26, 2024